-
Biotech
Idorsia’s selatogrel hits goals in phase 2 cardiovascular trials
[ad_1] Idorsia’s P2Y12 receptor antagonist selatogrel has considerably inhibited platelet aggregation in two phase 2 trials. The major endpoint successes…
Read More » -
News
China Stocks For 2019 And Beyond
[ad_1] 2018 is shortly coming to an in depth. For these of us concerned within the Chinese market, this cannot…
Read More » -
News
Dow up triple digits as U.S. stocks reassemble early gains
[ad_1] Dow up triple digits as U.S. stocks reassemble early gains [ad_2] Source link
Read More » -
News
Dow industrials up just a handful of points as post-Christmas rebound weakens
[ad_1] Dow industrials up just a handful of points as post-Christmas rebound weakens [ad_2] Source link
Read More » -
Cannabis
MYM Shifts Focus in Australia
[ad_1] Vancouver, British Columbia — December 26, 2018 — /D.M.O. Newswire/ — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or “The Company”) pronounces…
Read More » -
News
Mastercard Rises 3% By Investing.com
[ad_1] Investing.com – Mastercard (NYSE:) rose by 3.23% to commerce at $180.29 by 09:33 (14:33 GMT) on Wednesday on the…
Read More » -
News
Eramet: Rock-Solid Balance Sheet And Strong Rebound Potential For This Nickel-Manganese Miner – Eramet-SLN (OTCMKTS:ERMAF)
[ad_1] Eramet S.A. – Primary ticker: ERA:PA – solely the Euronext-traded shares supply correct liquidity. ADR: OTCPK:ERMAY, Grey Market: OTC:ERMAF.…
Read More » -
News
China stocks lower at close of trade; Shanghai Composite down 0.26% By Investing.com
[ad_1] © Reuters. China stocks lower at close of commerce; Shanghai Composite down 0.26% Investing.com – China stocks had been…
Read More » -
Cannabis
Israel’s Cannabis Industry Leads the Way in the Global Industry
[ad_1] Israel’s hashish business is getting ready to grow to be a global large. Israel’s hashish business has a protracted…
Read More » -
Biotech
Sophiris slides on prostate cancer data but vows to press on
[ad_1] Sophiris Bio is adamant that it’s going to advance its lead drug topsalysin into section 3 testing, after a…
Read More »
